Canada Post Corp Registered Pension Plan Raises Holdings in Cigna Group $CI

Canada Post Corp Registered Pension Plan boosted its stake in Cigna Group (NYSE:CIFree Report) by 545.3% during the third quarter, Holdings Channel.com reports. The institutional investor owned 26,888 shares of the health services provider’s stock after acquiring an additional 22,721 shares during the period. Canada Post Corp Registered Pension Plan’s holdings in Cigna Group were worth $7,707,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of CI. Massachusetts Financial Services Co. MA increased its position in Cigna Group by 1.1% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 11,778,472 shares of the health services provider’s stock worth $3,893,727,000 after purchasing an additional 123,479 shares in the last quarter. Dodge & Cox boosted its stake in shares of Cigna Group by 0.7% during the 2nd quarter. Dodge & Cox now owns 8,950,610 shares of the health services provider’s stock worth $2,958,893,000 after purchasing an additional 60,877 shares during the last quarter. Norges Bank purchased a new stake in shares of Cigna Group during the second quarter worth about $1,110,426,000. Arrowstreet Capital Limited Partnership raised its position in shares of Cigna Group by 24.4% in the second quarter. Arrowstreet Capital Limited Partnership now owns 2,508,740 shares of the health services provider’s stock valued at $829,339,000 after buying an additional 492,045 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in Cigna Group by 0.7% during the second quarter. Charles Schwab Investment Management Inc. now owns 2,052,912 shares of the health services provider’s stock worth $678,652,000 after acquiring an additional 15,014 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Performance

NYSE CI opened at $292.29 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.76. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00. The firm has a market capitalization of $78.08 billion, a P/E ratio of 13.18, a P/E/G ratio of 1.01 and a beta of 0.27. The business’s 50-day simple moving average is $274.77 and its 200-day simple moving average is $283.95.

Cigna Group (NYSE:CIGet Free Report) last posted its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, beating the consensus estimate of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The firm had revenue of $72.50 billion for the quarter, compared to analyst estimates of $69.53 billion. During the same quarter last year, the firm posted $6.64 earnings per share. Cigna Group’s revenue for the quarter was up 10.4% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Equities analysts predict that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Thursday, March 5th will be issued a $1.56 dividend. The ex-dividend date is Thursday, March 5th. This represents a $6.24 annualized dividend and a yield of 2.1%. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s payout ratio is currently 26.64%.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on CI shares. Morgan Stanley reiterated an “overweight” rating and issued a $355.00 price target on shares of Cigna Group in a report on Friday, October 31st. Sanford C. Bernstein reiterated a “market perform” rating and issued a $307.00 target price on shares of Cigna Group in a research note on Tuesday, January 6th. TD Cowen set a $333.00 price target on Cigna Group in a research note on Monday, December 15th. Royal Bank Of Canada dropped their price objective on shares of Cigna Group from $344.00 to $333.00 and set an “outperform” rating for the company in a research note on Friday. Finally, Truist Financial increased their price objective on shares of Cigna Group from $310.00 to $320.00 and gave the stock a “buy” rating in a report on Monday, January 5th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $323.16.

Check Out Our Latest Research Report on CI

Key Cigna Group News

Here are the key news stories impacting Cigna Group this week:

  • Positive Sentiment: Q4 earnings and revenue beat — Cigna reported adjusted EPS of $8.08 and revenue of $72.5B, both above consensus, driven by Evernorth growth and higher specialty volumes; investors are rewarding the beat and evidence of durable revenue momentum. Cigna Q4 Highlights
  • Positive Sentiment: FTC settlement over insulin pricing reduces regulatory overhang and includes commitments to change PBM pricing practices — this removes a major legal uncertainty and may support multiple expansion. FTC Settlement Coverage
  • Positive Sentiment: Dividend increase — the board raised the quarterly dividend to $1.56 (3.3% increase), a modest buyback/dividend-friendly signal that supports income investors. Dividend Announcement
  • Neutral Sentiment: Analyst price target moves are mixed — Leerink raised its PT to $297 but kept a “market perform” rating, while RBC trimmed its PT to $333 but maintained an “outperform” view; these moves show cautious optimism but limited near-term upside consensus. Leerink PT Change RBC PT Change
  • Neutral Sentiment: Evernorth and specialty volumes are growth drivers cited on the call — supportive for revenue mix and long-term profit potential, though investors will watch margin dynamics. Evernorth Growth Coverage
  • Negative Sentiment: 2026 guidance slightly below some Street expectations — Cigna set FY 2026 EPS guidance at at least $30.25, a touch under consensus and accompanied by commentary about ongoing medical-cost and margin pressure; this tempered the upside from the quarter for some investors. Guidance Miss Coverage

Cigna Group Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Featured Stories

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.